Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide

被引:124
作者
Boger, DL
Patterson, JE
Guan, XJ
Cravatt, BF
Lerner, RA
Gilula, NB
机构
[1] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1073/pnas.95.9.4810
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Oleamide is an endogenous fatty acid primary amide that possesses sleep-inducing properties in animals and has been shown to effect serotonergic systems and block gap junction communication in a structurally specific manner. Herein, the structural features of oleamide required for inhibition of the gap junction-mediated chemical and electrical transmission in rat glial cells are defined. The effective inhibitors fall into two classes of fatty acid primary amides of which oleamide and arachidonamide are the prototypical members, Of these two, oleamide constitutes the most effective, and its structural requirements for inhibition of the gap junction are well defined, It requires a chain length of 16-24 carbons of which 16-18 carbons appears optimal, a polarized terminal carbonyl group capable of accepting but not necessarily donating a hydrogen bond, a Delta(9) cis double bond, and a hydrophobic methyl terminus. Within these constraints, a range of modifications are possible, many of which may be expected to improve in vi,ro properties. A select set of agents has been identified that serves both as oleamide agonists and as inhibitors of fatty acid amide hydrolase, which is responsible for the rapid inactivation of oleamide.
引用
收藏
页码:4810 / 4815
页数:6
相关论文
共 49 条
  • [1] (R)-METHANANDAMIDE - A CHIRAL NOVEL ANANDAMIDE POSSESSING HIGHER POTENCY AND METABOLIC STABILITY
    ABADJI, V
    LIN, SY
    TAHA, G
    GRIFFIN, G
    STEVENSON, LA
    PERTWEE, RG
    MAKRIYANNIS, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (12) : 1889 - 1893
  • [2] ADAMS IB, 1995, J PHARMACOL EXP THER, V273, P1172
  • [3] PHARMACOLOGICAL AND BEHAVIORAL-EVALUATION OF ALKYLATED ANANDAMIDE ANALOGS
    ADAMS, IB
    RYAN, W
    SINGER, M
    RAZDAN, RK
    COMPTON, DR
    MARTIN, BR
    [J]. LIFE SCIENCES, 1995, 56 (23-24) : 2041 - 2048
  • [4] IDENTIFICATION OF FATTY-ACID AMIDES IN HUMAN-PLASMA
    ARAFAT, ES
    TRIMBLE, JW
    ANDERSEN, RN
    DASS, C
    DESIDERIO, DM
    [J]. LIFE SCIENCES, 1989, 45 (18) : 1679 - 1687
  • [5] AYLSWORTH CF, 1986, CANCER RES, V46, P4527
  • [6] BACHUR NR, 1965, J BIOL CHEM, V240, P1019
  • [7] Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide
    Boger, DL
    Patterson, JE
    Jin, Q
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) : 4102 - 4107
  • [8] UNCOUPLING OF CARDIAC-CELLS BY FATTY-ACIDS - STRUCTURE-ACTIVITY-RELATIONSHIPS
    BURT, JM
    MASSEY, KD
    MINNICH, BN
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (03): : C439 - C448
  • [9] Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
    Cravatt, BF
    Giang, DK
    Mayfield, SP
    Boger, DL
    Lerner, RA
    Gilula, NB
    [J]. NATURE, 1996, 384 (6604) : 83 - 87
  • [10] CHEMICAL CHARACTERIZATION OF A FAMILY OF BRAIN LIPIDS THAT INDUCE SLEEP
    CRAVATT, BF
    PROSPEROGARCIA, O
    SIUZDAK, G
    GILULA, NB
    HENRIKSEN, SJ
    BOGER, DL
    LERNER, RA
    [J]. SCIENCE, 1995, 268 (5216) : 1506 - 1509